Interleukin-1 receptor antagonist gene polymorphisms are associated with disease severity in Black South Africans with rheumatoid arthritis

Joint Bone Spine

Volumn 75, Issue 4, 2008, Pages 422-425

  Lubbe, Steven ^a,b   Tikly, Mohammed ^b,c   van der Merwe, Lize ^d   Hodkinson, Bridget ^b,c   Ramsay, Michele ^a,b  

^a NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

Africa; Blacks; Genetics; Interleukin 1; Rheumatoid arthritis

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA;

ADULT; ALLELE; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; FOOT RADIOGRAPHY; GENE CLUSTER; GENE FREQUENCY; GENE LOCUS; GENETIC POLYMORPHISM; GENOTYPE; HAND RADIOGRAPHY; HAPLOTYPE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGRO; POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SOUTH AFRICA; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; MALE; POLYMORPHISM, GENETIC; SEVERITY OF ILLNESS INDEX; SOUTH AFRICA; TANDEM REPEAT SEQUENCES;

EID: 46449133255     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2007.09.015     Document Type: Article

References (24)

1. Silman A.J., and Pearson J.E. Epidemiology and genetics of rheumatoid arthritis. Arthritis Res 4 Suppl. 3 (2002) S265-S272
2. Iwakura Y. Roles of IL-1 in the development of rheumatoid arthritis: consideration from mouse models. Cytokine Growth Factor Rev 13 (2002) 341-355
3. Smith D.E., Renshaw B.R., Ketchem R.R., et al. Four new members expand the interleukin-1 superfamily. J Biol Chem 275 (2000) 1169-1175
4. Buchs N., di Giovine F.S., Silvestri T., et al. IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: interaction with their plasma levels. Genes Immun 2 (2001) 222-228
5. Cantagrel A., Navaux F., Loubet-Lescoulie P., et al. Interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum 42 (1999) 1093-1100
6. Cvetkovic J.T., Wallberg-Jonsson S., Stegmayr B., et al. Susceptibility for and clinical manifestations of rheumatoid arthritis are associated with polymorphisms of the TNF-alpha, IL-1beta, and IL-1Ra genes. J Rheumatol 29 (2002) 212-219
7. Vencovsky J., Jarosova K., Ruzickova S., et al. Higher frequency of allele 2 of the interleukin-1 receptor antagonist gene in patients with juvenile idiopathic arthritis. Arthritis Rheum 44 (2001) 2387-2391
8. Huang C.M., Tsai F.J., Wu J.Y., et al. Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in rheumatoid arthritis. Scand J Rheumatol 30 (2001) 225-228
9. Carreira P.E., Gonzalez-Crespo M.R., Ciruelo E., et al. Polymorphism of the interleukin-1 receptor antagonist gene: a factor in susceptibility to rheumatoid arthritis in a Spanish population. Arthritis Rheum 52 (2005) 3015-3019
10. Cox A., Camp N.J., Cannings C., et al. Combined sib-TDT and TDT provide evidence for linkage of the interleukin-1 gene cluster to erosive rheumatoid arthritis. Hum Mol Genet 8 (1999) 1707-1713
11. Pile K.D., Tikly M., Bell J.I., et al. HLA-DR antigens and rheumatoid arthritis in black South Africans: a study of ethnic groups. Tissue Antigens 39 (1992) 138-140
12. Baerwald C.G., Mok C.C., Tickly M., et al. Corticotropin releasing hormone (CRH) promoter polymorphisms in various ethnic groups of patients with rheumatoid arthritis. Z Rheumatol 59 (2000) 29-34
13. MacKay K., Milicic A., Lee D., et al. Rheumatoid arthritis susceptibility and interleukin 10: a study of two ethnically diverse populations. Rheumatology 42 (2003) 149-153
14. Arnett F.C., Edworthy S.M., Bloch D.A., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31 (1988) 315-324
15. Pincus T., Summey J.A., Soraci S.A.J., et al. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 26 (1983) 1346-1353
16. Wick M., Peloschek P., Bogl K., et al. The "X-Ray RheumaCoach" software: a novel tool for enhancing the efficacy and accelerating radiological quantification in rheumatoid arthritis. Ann Rheum Dis 62 (2003) 579-582
17. Tolusso B., Pietrapertosa D., Morelli A., et al. IL-1B and IL-1RN gene polymorphisms in rheumatoid arthritis: relationship with protein plasma levels and response to therapy. Pharmacogenomics 7 (2006) 683-695
18. Schaid D.J., Rowland C.M., Tines D.E., et al. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70 (2002) 425-434
19. R Development Core Team. R: a language and environment for statistical computing (2006), R Foundation for Statistical Computing, Vienna. http://www.R-project.org
20. Grover S., Tandon S., Misra R., et al. Interleukin-1 receptor antagonist gene polymorphism in patients with rheumatoid arthritis in India. Indian J Med Res 123 (2006) 815-820
21. Genevay S., Di Giovine F.S., Perneger T.V., et al. Association of interleukin-4 and interleukin-1B gene variants with Larsen score progression in rheumatoid arthritis. Arthritis Rheum 47 (2002) 303-309
22. Carter M.J., Jones S., Camp N.J., et al. Functional correlates of the interleukin-1 receptor antagonist gene polymorphism in the colonic mucosa in ulcerative colitis. Genes Immun 5 (2004) 8-15
23. Arman A., Yilmaz B., Coker A., et al. Interleukin-1 receptor antagonist (IL-1RN) and interleukin-1B gene polymorphisms in Turkish patients with rheumatoid arthritis. Clin Exp Rheumatol 24 (2006) 643-648
24. Breedveld F.C., Han C., Bala M., et al. Association between baseline radiographic damage and improvement in physical function after treatment of patients with rheumatoid arthritis. Ann Rheum Dis 64 (2005) 52-55